Incidence, Predictors, and Significance of Abnormal Cardiac Enzyme Rise in Patients Treated With Bypass Surgery in the Arterial Revascularization Therapies Study (ARTS)

Background—Although it has been suggested that elevation of CK-MB after percutaneous coronary intervention is associated with adverse clinical outcomes, limited data are available in the setting of coronary bypass grafting. The aim of the present study was to determine the incidence, predictors, and prognostic significance of CK-MB elevation following multivessel coronary bypass grafting (CABG). Methods and Results—The population comprises 496 patients with multivessel coronary disease assigned to CABG in the Arterial Revascularization Therapies Study (ARTS). CK-MB was prospectively measured at 6, 12, and 18 hours after the procedure. Thirty-day and 1-year clinical follow-up were performed. Abnormal CK-MB elevation occurred in 61.9% of the patients. Patients with increased cardiac-enzyme levels after CABG were at increased risk of both death and repeat myocardial infarction within the first 30 days (P =0.001). CK-MB elevation was also independently related to late adverse outcome (P =0.009, OR=0.64). Conclusions—Increased concentrations of CK-MB, which are often dismissed as inconsequential in the setting of multivessel CABG, appear to occur very frequently and are associated with a significant increase in both repeat myocardial infarction and death beyond the immediate perioperative period.

[1]  E. Jones,et al.  Clinical significance of perioperative Q-wave myocardial infarction: the Emory Angioplasty versus Surgery Trial. , 1996, The Journal of thoracic and cardiovascular surgery.

[2]  M. R. Sayen,et al.  Insulin responsiveness of CK-M and CK-B mRNA in the diabetic rat heart. , 1991, The American journal of physiology.

[3]  G. Wagner,et al.  Diagnostic and prognostic significance of electrocardiographic and CPK isoenzyme changes following coronary bypass surgery: correlation with findings at one year. , 1977, American heart journal.

[4]  David P Miller,et al.  Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. , 1997, JAMA.

[5]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[6]  A. Van der Laarse,et al.  Recognition and quantification of myocardial injury by means of plasma enzyme and isoenzyme activities after cardiac surgery. , 1979, British heart journal.

[7]  Douglas G Altman,et al.  Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries , 2001, The Lancet.

[8]  R. Califf,et al.  Myonecrosis after revascularization procedures. , 1998, Journal of the American College of Cardiology.

[9]  W. Laskey.  Beneficial impact of preconditioning during PTCA on creatine kinase release. , 1999, Circulation.

[10]  R. Bonow,et al.  Prognostic implication of creatine kinase elevation following elective coronary artery interventions. , 1997, JAMA.

[11]  P. Touboul,et al.  Troponin I, troponin T, or creatine kinase-MB to detect perioperative myocardial damage after coronary artery bypass surgery. , 1998, Chest.

[12]  E. Topol,et al.  The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. , 1996, Circulation.

[13]  David P Miller,et al.  Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention , 1997 .

[14]  R. Califf,et al.  Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). , 1995, Journal of the American College of Cardiology.

[15]  D. Taggart.  Biochemical assessment of myocardial injury after cardiac surgery: effects of a platelet activating factor antagonist, bilateral internal thoracic artery grafts, and coronary endarterectomy. , 2000, The Journal of thoracic and cardiovascular surgery.

[16]  R. E. Clark,et al.  The Association of Increased Plasma MB CPK Activity and Irreversible Ischemic Myocardial Injury in the Dog , 1976, Circulation.

[17]  E. Topol,et al.  Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. , 1996, Circulation.

[18]  S. Khuri,et al.  Perioperative myocardial infarction after coronary artery bypass surgery. Clinical significance and approach to risk stratification. , 1990, Circulation.

[19]  G. Stone,et al.  Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. , 2000, Journal of the American College of Cardiology.

[20]  M. Payne,et al.  Selective reduction of creatine kinase subunit mRNAs in striated muscle of diabetic rats. , 1992, The American journal of physiology.

[21]  R. Califf,et al.  Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction , 1997 .

[22]  R. Califf,et al.  Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention , 1999 .

[23]  C. Cannon,et al.  Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? , 1995, Circulation.

[24]  J. Matloff,et al.  CK-MB release following coronary artery bypass grafting in the absence of myocardial infarction. , 1983, The Annals of thoracic surgery.

[25]  P. Rehak,et al.  Preoperative Myocardial Cell Damage in Patients with Unstable Angina Undergoing Coronary Artery Bypass Graft Surgery , 1994, Anesthesiology.

[26]  C. Sylvén,et al.  Human myocardial and skeletal muscle enzyme activities: creatine kinase and its isozyme MB as related to citrate synthase and muscle fibre types. , 1983, Clinical physiology.

[27]  R. Califf,et al.  Minimal myocardial damage during coronary intervention is associated with impaired outcome. , 1999, European heart journal.

[28]  L. Klein,et al.  Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. , 1991, Journal of the American College of Cardiology.

[29]  G. Hempelmann,et al.  Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery? , 1996, Heart.

[30]  M. Newman,et al.  Drug therapy before coronary artery surgery: nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival. , 1999 .